656
Views
0
CrossRef citations to date
0
Altmetric
Cancer Biology

Bioinformatics analysis reveals the changes of peroxisome proliferator-activated receptor (PPAR) pathway in the development of Marjolin ulcers

, , , , &
Pages 960-969 | Received 31 May 2022, Accepted 11 Jul 2022, Published online: 19 Sep 2022

References

  • Baldursson B, Sigurgeirsson B, Lindelöf B. 1995. Venous leg ulcers and squamous cell carcinoma a large-scale epidemiological study. Br J Dermatol. 133:571–574.
  • Bazaliński D, Przybek-Mita J, Barańska B, Więch P. 2017. Marjolin’s ulcer in chronic wounds - review of available literature. Contemp Oncol (Poznan, Poland). 21:197–202.
  • Berger J, Moller DE. 2002. The mechanisms of action of PPARs. Annu Rev Med. 53(1):409–435.
  • Bostwick J, PendergrastJrWJ, Vasconez LOJP, Surgery R. 1976. Marjolins ulcer. Plast Reconstr Surg. 57(1):66–69.
  • Chen S, Xu H, Hu F, Wang T. 2020. Identification of Key players involved in CoCl2 hypoxia induced pulmonary artery hypertension in vitro. Front Genet. 11:232.
  • Coussens LM, Werb Z. 2002. Inflammation and cancer. Nature. 420:860–867.
  • Esther RJ, Lamps L, Schwartz HS. 1999. Marjolin ulcers: secondary carcinomas in chronic wounds. J South Orthop Assoc. 8:181–187.
  • Fucci A, Colangelo T, Votino C, Pancione M, Sabatino L, Colantuoni V. 2012. The role of peroxisome proliferator-activated receptors in the esophageal, gastric, and colorectal cancer. PPAR Res. 2012:1.
  • Gene Ontology Consortium. 2019. The gene ontology resource: 20 years and still GOing strong. Nucleic Acids Res. 47:D330–D338.
  • Gong R, Chen M, Zhang C, Chen M, Li H. 2017. A comparison of gene expression profiles in patients with coronary artery disease, type 2 diabetes, and their coexisting conditions. Diagn Pathol. 12:44.
  • Grenier JM, Barrière I, Rouffy J. 1993. Transformation maligne des ulcères des membres inférieurs. Rev Med Interne. 14:51–53.
  • Harland DL, Robinson WA, Franklin WA. 1997. Deletion of the p53 gene in a patient with aggressive burn scar carcinoma. J Trauma: Inj Infection Crit Care. 42(1):104–107.
  • Jensen JM, Proksch E. 2009. The skin’s barrier. G Ital Dermatol Venereol. 144:689–700.
  • Kanehisa M, Goto S. 2000. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30.
  • Kerr-Valentic MA, Samimi K, Rohlen BH, Agarwal JP, Rockwell WB. 2009. Marjolin’s ulcer: modern analysis of an ancient problem. Plastic Reconstructive Surgery. 123:184–191.
  • Keshava Prasad TS, Goel R, Kandasamy K, Keerthikumar S, Kumar S, Mathivanan S, Telikicherla D, Raju R, Shafreen B, Venugopal A, Balakrishnan L. 2009. Human protein reference database–2009 update. Nucleic Acids Res. 37:D767–D772.
  • Khaidakov M, Mitra S, Kang BY, Wang X, Kadlubar S, Novelli G, Raj V, Winters M, Carter WC, Mehta JL. 2011. Oxidized LDL receptor 1 (OLR1) as a possible link between obesity, dyslipidemia and cancer. PLoS One. 6:e20277.
  • Kim D, Langmead B, Salzberg SL. 2015. HISAT: a fast spliced aligner with low memory requirements. Nat Methods. 12:357–360.
  • Kleine AH, Glatz JFC, Van Nieuwenhoven FA, Van Der Vusse GJ. 1992. Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man. Mol Cell Biochem. 116:155–162.
  • Konger RL, Derr-Yellin E, Ermatov N, Ren L, Sahu RP. 2019. The PPARγ agonist rosiglitazone suppresses syngeneic mouse SCC (squamous cell carcinoma) tumor growth through an immune-mediated mechanism. Molecules. 24:2192.
  • Lee SH, Shin MS, Kim HS, Park WS, Kim SY, Jang J, Lee HK, Park JY, Oh RR, Han SY, Lee JH. 2000. Somatic mutations of Fas (Apo-1/CD95) gene in cutaneous squamous cell carcinoma arising from a burn scar. J Invest Dermatol. 114:122–126.
  • Li B, Dewey CN. 2011. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics. 12:323.
  • Lian M, Chen J, Shen X, Hou L, Fang J. 2020. Pparg may promote chemosensitivity of hypopharyngeal squamous cell carcinoma. PPAR Res. 2020:1.
  • Lian M, Tao Y, Chen J, Shen X, Hou L, Cao S, Fang J. 2021. Variation of PPARG expression in chemotherapy-sensitive patients of hypopharyngeal squamous cell carcinoma. PPAR Res. 2021:1.
  • Liu Z, Ren L, Tian J, Liu N, Hu Y, Zhang P. 2018. Comprehensive analysis of long noncoding RNAs and messenger RNAs expression profiles in patients with marjolin ulcer. Med Sci Monit. 24:7828–7840.
  • Luo W, Pant G, Bhavnasi YK, Blanchard SG, Jr, Brouwer C. 2017. Pathview Web: user friendly pathway visualization and data integration. Nucleic Acids Res. 45:W501–W508.
  • Man MQ, Choi EH, Schmuth M, Crumrine D, Uchida Y, Elias PM, Holleran WM, Feingold KR. 2006. Basis for improved permeability barrier homeostasis induced by PPAR and LXR activators: liposensors stimulate lipid synthesis, lamellar body secretion, and post-secretory lipid processing. J Invest Dermatol. 126:386–392.
  • Masuda T, Wada K, Nakajima A, Okura M, Kudo C, Kadowaki T, Kogo M, Kamisaki Y. 2005. Critical role of peroxisome proliferator-activated receptor γ on anoikis and invasion of squamous cell carcinoma. Clin Cancer Res. 11:4012–4021.
  • Michalik L, Auwerx J, Berger JP, Chatterjee VK, Glass CK, Gonzalez FJ, Grimaldi PA, Kadowaki T, Lazar MA, O’rahilly S, et al. 2006. International union of pharmacology. LXI. Peroxisome Proliferator-Activated Receptors. 58:726–741.
  • Nijsten T, Geluyckens E, Colpaert C, Lambert J. 2005. Peroxisome proliferator-activated receptors in squamous cell carcinoma and its precursors. J Cutan Pathol. 32:340–347.
  • Pavlovic S, Wiley E, Guzman G, Morris D, Braniecki M. 2011. Marjolin ulcer: an overlooked entity. Int Wound J. 8:419–424.
  • Pekarek B, Buck S, Osher L. 2011. A comprehensive review on marjolin’s ulcers: diagnosis and treatment. J Am Col Certif Wound Spec. 3:60–64.
  • Pertea M, Pertea GM, Antonescu CM, Chang TC, Mendell JT, Salzberg SL. 2015. Stringtie enables improved reconstruction of a transcriptome from RNA-seq reads. Nat Biotechnol. 33:290–295.
  • Piel FB, Steinberg MH, Rees DC. 2017. Sickle cell disease. N Engl J Med. 376:1561–1573.
  • Ren L, Konger RL. 2019. Evidence that peroxisome proliferator-activated receptor γ suppresses squamous carcinogenesis through anti-inflammatory signaling and regulation of the immune response. Mol Carcinog. 58:1589–1601.
  • Robinson MD, Mccarthy DJ, Smyth GK. 2010. Edger: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 26:139–140.
  • Sahu RP, Dasilva SC, Rashid B, Martel KC, Jernigan D, Mehta SR, Mohamed DR, Rezania S, Bradish JR, Armstrong AB, et al. 2012. Mice lacking epidermal PPARγ exhibit a marked augmentation in photocarcinogenesis associated with increased UVB-induced apoptosis, inflammation and barrier dysfunction. Int J Cancer. 131:E1055–E1066.
  • Sawayama H, Ishimoto T, Watanabe M, Yoshida N, Sugihara H, Kurashige J, Hirashima K, Iwatsuki M, Baba Y, Oki E, et al. 2014. Small molecule agonists of PPAR-γ exert therapeutic effects in esophageal cancer. Cancer Res. 74:575–585.
  • Shah M, Crane JS. 2022. Marjolin ulcer. In: Statpearls. StatPearls publishing copyright © 2022. Treasure Island (FL): StatPearls Publishing LLC.
  • Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. 2003. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13:2498–2504.
  • Shi T, Shen X, Gao G. 2019. Gene expression profiles of peripheral blood monocytes in osteoarthritis and analysis of differentially expressed genes. BioMed Res Int. 2019:4291689.
  • Shiba N, Yoshida K, Hara Y, Yamato G, Shiraishi Y, Matsuo H, Okuno Y, Chiba K, Tanaka H, Kaburagi T, Takeuchi M. 2019. Transcriptome analysis offers a comprehensive illustration of the genetic background of pediatric acute myeloid leukemia. Blood Adv. 3:3157–3169.
  • Sinha S, Su S, Workentine M, Agabalyan N, Cheng M, Gabriel V, Biernaskie J. 2017. Transcriptional analysis reveals evidence of chronically impeded ECM turnover and epithelium-to-mesenchyme transition in scar tissue giving rise to marjolin’s ulcer. J Burn Care Res. 38:e14–e22.
  • Sturm M, Schroeder C, Bauer P. 2016. Seqpurge: highly-sensitive adapter trimming for paired-end NGS data. BMC Bioinformatics. 17:208.
  • Treves NJSGO. 1930. The development of cancer in burn scars: an analysis and report of thirty-four cases. Surg Gynecol Obstet. 51:749–782.
  • Tseng CH. 2014. Pioglitazone and oral cancer risk in patients with type 2 diabetes. Oral Oncol. 50:98–103.
  • Tsukahara R, Haniu H, Matsuda Y, Tsukahara T. 2014. Heart-type fatty-acid-binding protein (FABP3) is a lysophosphatidic acid-binding protein in human coronary artery endothelial cells. FEBS Open Bio. 4:947–951.
  • Wang C, Song C, Liu Q, Zhang R, Fu R, Wang H, Yin D, Song W, Zhang H, Dou K. 2021. Gene expression analysis suggests immunological changes of peripheral blood monocytes in the progression of patients With coronary artery disease. Front Genet. 12:641117.
  • Wang Z, Gerstein M, Snyder M. 2009. RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet. 10:57–63.
  • Xiang F, Song HP, Huang YS. 2019. Clinical features and treatment of 140 cases of marjolin’s ulcer at a major burn center in southwest China. Exp Ther Med. 17:3403–3410.
  • Xu F, Lu C, Wu Q, Gu W, Chen J, Fang F, Zhao B, Du W, You M. 2018. Studies on the lipid-regulating mechanism of alisol-based compounds on lipoprotein lipase. Bioorg Chem. 80:347–360.
  • Xu G, Wang YM, Ying MM, Chen SD, Li ZR, Ma HL, Zheng MH, Wu J, Ding C. 2021. Serum lipocalin-2 is a potential biomarker for the clinical diagnosis of nonalcoholic steatohepatitis. Clin Mol Hepatol. 27:329–345.
  • Yu G, Wang LG, Han Y, He QY. 2012. Clusterprofiler: an R package for comparing biological themes among gene clusters. OMICS: A J Integr Biol. 16:284–287.